UChicago Medicine Receives $75 Million Donation for New Cancer Pavilion
AbbVie Foundation Contributes to State-of-the-Art Facility
University of Chicago Medicine has received a $75 million donation from the AbbVie Foundation to support the construction of a new cancer pavilion on its Hyde Park campus. The facility, set to open in 2027, will be named after the nonprofit and will serve as a hub for cancer prevention, screening, and diagnoses.
Transforming Cancer Care
The new center will streamline the process for patients receiving care, consolidating services currently spread across five buildings on the campus. It will feature a ground-floor space for community outreach, private infusion bays, and a dedicated breast center. The facility will also include 80 inpatient beds, including 64 medical-surgical beds and a 16-bed intensive care unit, as well as infusion therapy with private rooms grouped by cancer type, a cancer imaging suite, and dedicated clinical trial spaces.
Enhancing Patient Experience
The updated design of the center reflects patient needs, with features such as a community hub for cancer prevention, screening, and diagnoses, private infusion bays, and a dedicated breast center. The facility will also provide around 200,000 outpatient visits and 5,000 inpatient admissions annually, freeing up space at the University of Chicago Medical Center.
A Commitment to Health Equity
The AbbVie Foundation and UChicago Medicine have a long-standing partnership to advance health equity on the city’s South Side. The foundation has committed $8 million over five years to support the establishment of the Liaisons in Care program.
Leaders’ Statements
“We are deeply honored by this generous donation, as it strengthens our commitment to advancing the health and vitality of the community – a core priority of our South Side-based institution,” said Paul Alivisatos, president of the University of Chicago. “This significant contribution speaks to the confidence that the AbbVie Foundation has in UChicago as a pioneering medical institution dedicated to pursuing globally meaningful solutions to yet-unsolved challenges.”
“The AbbVie Foundation is honored to deepen our longstanding partnership with UChicago Medicine, which is rooted in our shared mission to advance health equity,” said Claudia Carravetta, president of the foundation. “We are proud to contribute to this state-of-the-art facility, which will support UChicago Medicine’s efforts to accelerate access and innovations in cancer care, addressing inequities and creating a remarkable impact for patients in Chicago’s South Side community and around the world.”
FAQs
* What is the total cost of the cancer pavilion project?
+ The updated estimated cost is $815 million.
* What is the expected timeline for the completion of the cancer pavilion?
+ The pavilion is set to open in 2027.
* What services will be offered at the cancer pavilion?
+ The facility will offer a range of services, including cancer prevention, screening, and diagnoses, as well as infusion therapy, cancer imaging, and clinical trial spaces.
* How many inpatient beds will the cancer pavilion have?
+ The facility will have 80 inpatient beds, including 64 medical-surgical beds and a 16-bed intensive care unit.
